Repligen (RGEN) reported Q3 adjusted earnings Tuesday of $0.43 per diluted share, up from $0.23 a year earlier.
Analysts polled by Capital IQ expected $0.33.
Total revenue for the quarter ended Sept. 30 was $154.9 million, up from $141.2 million a year earlier.
Analysts surveyed by Capital IQ expected $153.3 million.
For 2024, the company said it now expects adjusted earnings of $1.50 to $1.58 per diluted share, compared with $1.42 to $1.49 previously. Analysts polled by Capital IQ expect $1.49.
Total reported revenue for the year is now expected to be in the range of $630 million to $639 million, narrowed from the previous outlook of $627 million to $642 million provided by the company in September. Analysts surveyed by Capital IQ expect $629.7 million.
Repligen's shares were up more than 7% in recent premarket activity.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。